… In patients on anticoagulant treatment, the major bleeding (MB) definition released by the
International Society of Thrombosis and Haemostasis (ISTH) is widely accepted. However, this …

… related major bleeding were included. The pooled proportion of patients with effective
management of major bleeding … alone in patients with direct FXa inhibitor–related major bleeding. …

… -related bleeding is highest at the start of therapy: during warfarin therapy, the risk for major
bleeding during … An individual patient's risk for major anticoagulant-related bleeding can be …

… - and 11 dabigatran-associated major bleeding events included in a prospective … -related
major bleeding events in our study. Furthermore, all-cause mortality following major bleeding …

… For example, in the RIVAL study69 non-CABG related major bleeding as defined by the
study was not significantly different between the radial and femoral arms of the study (OR=0.73, …

… course of DOAC-related bleeding, although cancer patients were … course of
anticoagulant-related major bleeding episodes are not … with an anticoagulant-related major …

… major bleeding events in 1034 patients enrolled in 5 phase III trials [1], [2], [3], [4] has previously
been published [14]. Patients who experienced major bleeding … of major bleeding events …

… In conclusion, although major bleeding seems to be rare in Covid-19 patients, its management
is complex for several reasons: the need to continue anticoagulation, shortage of blood …

… major bleeding varies between studies on surgical patients, particularly regarding the criteria
for surgical wound-related bleeding… for a harmonized definition of major bleeding in non-…

… There is a lack of data on factors that are related to clinically relevant bleeding after ticagrelor
treatment. We investigated the clinical and procedural factors related to major bleeding in …